Senior Computational Biologist

Merck & Co. is looking for a motivated Senior Computational Biologist to join our team and help us drive the next phase of scientific innovation. The Senior Computational Biologist will be a key contributor to our team, working with cutting-edge technology and developing solutions to complex problems and projects. This individual will have the opportunity to work with data from a variety of sources, including clinical and basic research, to create meaningful insights that help drive our business forward.This role requires a combination of technical and scientific expertise, and the ideal candidate will have a background in bioinformatics, data science, machine learning, or a related field. The successful candidate will have a deep understanding of statistical and genomic analysis methods, experience with high-throughput sequencing technologies, and strong computing skills. They will be comfortable working with large datasets, and able to develop and apply custom computational solutions to biological problems. Additionally, they will possess excellent communication and collaboration skills, allowing them to effectively work with a variety of teams and stakeholders. This is an exciting opportunity to join a dynamic and growing organization and make an impact on the future of healthcare.

According to JobzMall, the average salary range for a Senior Computational Biologist in Cambridge, MA, USA is $82,000 to $128,000 per year. This range is based on salaries reported by employers to JobzMall and includes salaries from all job levels, including entry-level, mid-level, and senior-level positions. The range may also vary depending on the employer, the candidate's experience and qualifications, the industry, and the job's location.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.